Featuring the Royal Society’s plan to combat the replication crisis, a new peer review tool for BMC journals, and the Open Pharma podcast!
Open access is a fantastic opportunity to make science accessible to all. Find out how to get all of the benefits without fearing the predators in our new podcast!
Featuring an interview with the architect of Plan S, the legal case being brought against ResearchGate, and a systematic review on the open access citation advantage.
Featuring the open access citation advantage for research into poverty-related disease, Finland’s decision to join Plan S, and how ORCID can help the pharmaceutical industry.
Our new educational resource, an infographic on ORCID, is now available on the Open Pharma website.
Featuring the FDA’s proposal to begin enforcing fines for research funders who don’t report their clinical trial results, the potential harms of over zealous ‘industry bashing’, and the barbecue joint for high impact authors.
Featuring the story of open citations, the science of publishing, and the new open source peer-review platform.
Featuring pharma taking the lead on sharing clinical trial results, where preprints end up, and the identity of peer reviewers.
Would you like to share information or a point of view with the Open Pharma community?
Featuring the ground-shaking new ‘Plan-S’ open access commitments, a critical look at the ‘moral high ground’ of academia, and open access: the movie.